ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Internal Medicine

Top Internal Medicine Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
RICHARD LONG MD

Internal Medicine

18,704

$1.23M

801
665 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $58

DIANN WESTRICK M.D.

Internal Medicine

18,622

$725K

560
501 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$39
Average prescription price

Avg: $58

EDWARD CIKOWSKI DO

Internal Medicine

18,619

$987K

677
624 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $58

WALTER ROBISON M.D.

Internal Medicine

18,599

$992K

723
667 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $58

VERA SHERMAN M.D.

Internal Medicine

18,407

$92.3K

241
184 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$5
Average prescription price

Avg: $58

THOMAS HEPNER M.D.

Internal Medicine

18,320

$772K

792
653 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

6%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$42
Average prescription price

Avg: $58

FRANK MORO MD

Internal Medicine

18,222

$1.44M

466
406 are 65+

5%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 25%

$79
Average prescription price

Avg: $58

PAWAN ARORA MD

Internal Medicine

18,207

$977K

502
482 are 65+

21%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $58

MICHAEL PETERSON D.O.

Internal Medicine

18,178

$1.14M

604
497 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $58

TROY JONES M.D.

Internal Medicine

18,149

$878K

819
699 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $58

ROBERT BRACKBILL M.D.

Internal Medicine

18,146

$874K

666
607 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $58

TAMRAT BEKELE MD

Internal Medicine

18,086

$892K

655
538 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $58

MICHAEL PISANO D.O.

Internal Medicine

17,887

$818K

455
368 are 65+

19%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $58

ROBERT MULTARI DO

Internal Medicine

17,879

$930K

459
195 are 65+

34%
patients receiving schedule two controlled substances

Avg: 7%

31%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $58

PETER VACCARO M.D.

Internal Medicine

17,825

$886K

551
472 are 65+

3%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $58

VANCE GOOD MD

Internal Medicine

17,808

$988K

555
424 are 65+

14%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $58

JAE HONG MD

Internal Medicine

17,751

$1.12M

570
435 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$63
Average prescription price

Avg: $58

SHIRISH PARIKH MD

Internal Medicine

17,730

$994K

411
331 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

17%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $58

JEFFREY HASSEL MD

Internal Medicine

17,670

$1.08M

573
449 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $58

RUDOLPH ANTONCIC MD

Internal Medicine

17,640

$877K

686
564 are 65+

4%
patients receiving schedule two controlled substances

Avg: 7%

12%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $58

THOMAS SHETTER MD

Internal Medicine

17,614

$1.24M

921
791 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$70
Average prescription price

Avg: $58

ABDUL MAKHDOMI M.D.

Internal Medicine

17,608

$1.02M

565
494 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $58

DANIEL ERLANGER D.O.

Internal Medicine

17,574

$961K

1080
973 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $58

CYNTHIA RECINTO M.D.

Internal Medicine

17,490

$981K

556
478 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $58

ANANT GANDHI MD

Internal Medicine

17,324

$1.18M

759
552 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

19%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$68
Average prescription price

Avg: $58

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank